Scott A Rutherford|Paul D Smith - JoVE Visualize

Showing results (141-150 of 212) with videos related to

Pageof 22

Sort By:

Cancer Research|September 20, 2017

MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance SpectroscopyMounia Beloueche-Babari, Slawomir Wantuch, Teresa Casals Galobart, et al.

Pediatric Blood & Cancer|May 19, 2015

Inhibition of MEK confers hypersensitivity to X-radiation in the context of BRAF mutation in a model of childhood astrocytomaAdam Studebaker, Kathryn Bondra, Star Seum, et al.

Implementation Science : IS|November 24, 2014

Leveraging practice-based research networks to accelerate implementation and diffusion of chronic kidney disease guidelines in primary care practices: a prospective cohort studyJames W Mold, Cheryl B Aspy, Paul D Smith, et al.

BMC Family Practice|November 29, 2020

Increasing system-wide implementation of opioid prescribing guidelines in primary care: findings from a non-randomized stepped-wedge quality improvement projectAleksandra E Zgierska, James M Robinson, Robert P Lennon, et al.

International Journal of Chronic Obstructive Pulmonary Disease|February 18, 2020

Dual Role For A MEK Inhibitor As A Modulator Of Inflammation And Host Defense Mechanisms With Potential Therapeutic Application In COPDNisha Kurian, Taylor S Cohen, Lisa Öberg, et al.

Neurosurgery|October 4, 2017

Malignant Peripheral Nerve Sheath Tumors are not a Feature of Neurofibromatosis Type 2 in the Unirradiated PatientAndrew T King, Scott A Rutherford, Charlotte Hammerbeck-Ward, et al.

Plos One|January 4, 2014

Evaluation of non-invasive multispectral imaging as a tool for measuring the effect of systemic therapy in Kaposi sarcomaJana M Kainerstorfer, Mark N Polizzotto, Thomas S Uldrick, et al.

Nature Communications|March 20, 2021

Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancersTereza Vaclova, Ursula Grazini, Lewis Ward, et al.

Pigment Cell & Melanoma Research|December 24, 2010

A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation statusMarie C Zipser, Ossia M Eichhoff, Daniel S Widmer, et al.

Biomedical Optics Express|May 12, 2011

Quantitative principal component model for skin chromophore mapping using multi-spectral images and spatial priorsJana M Kainerstorfer, Jason D Riley, Martin Ehler, et al.

Pageof 22

Showing results (141-150 of 212) with videos related to

Sort By:

Pageof 22

Cancer Research|September 20, 2017

MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance SpectroscopyMounia Beloueche-Babari, Slawomir Wantuch, Teresa Casals Galobart, et al.

Pediatric Blood & Cancer|May 19, 2015

Inhibition of MEK confers hypersensitivity to X-radiation in the context of BRAF mutation in a model of childhood astrocytomaAdam Studebaker, Kathryn Bondra, Star Seum, et al.

Implementation Science : IS|November 24, 2014

Leveraging practice-based research networks to accelerate implementation and diffusion of chronic kidney disease guidelines in primary care practices: a prospective cohort studyJames W Mold, Cheryl B Aspy, Paul D Smith, et al.

BMC Family Practice|November 29, 2020

Increasing system-wide implementation of opioid prescribing guidelines in primary care: findings from a non-randomized stepped-wedge quality improvement projectAleksandra E Zgierska, James M Robinson, Robert P Lennon, et al.

International Journal of Chronic Obstructive Pulmonary Disease|February 18, 2020

Dual Role For A MEK Inhibitor As A Modulator Of Inflammation And Host Defense Mechanisms With Potential Therapeutic Application In COPDNisha Kurian, Taylor S Cohen, Lisa Öberg, et al.

Neurosurgery|October 4, 2017

Malignant Peripheral Nerve Sheath Tumors are not a Feature of Neurofibromatosis Type 2 in the Unirradiated PatientAndrew T King, Scott A Rutherford, Charlotte Hammerbeck-Ward, et al.

Plos One|January 4, 2014

Evaluation of non-invasive multispectral imaging as a tool for measuring the effect of systemic therapy in Kaposi sarcomaJana M Kainerstorfer, Mark N Polizzotto, Thomas S Uldrick, et al.

Nature Communications|March 20, 2021

Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancersTereza Vaclova, Ursula Grazini, Lewis Ward, et al.

Pigment Cell & Melanoma Research|December 24, 2010

A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation statusMarie C Zipser, Ossia M Eichhoff, Daniel S Widmer, et al.

Biomedical Optics Express|May 12, 2011

Quantitative principal component model for skin chromophore mapping using multi-spectral images and spatial priorsJana M Kainerstorfer, Jason D Riley, Martin Ehler, et al.

Pageof 22